Clearlake Capital-Backed Mold-Rite Packaging Names Healthcare Manufacturing Veteran Jim Fitzgerald as CEO – Yahoo Finance

Share Article

Argus's Jim Kelleher and John Eade break down stocks they see as well-positioned for 2022 on Wed, 2/9 at 2 PM ET.
Appointment signals next stage of growth and emphasis on health & wellness segments for MRP
SANTA MONICA, Calif., and PLATTSBURGH, N.Y., Feb. 3, 2022 /PRNewswire/ — Mold-Rite Packaging ("MRP", "Mold-Rite" or the "Company"), a provider of value-added packaging components, such as child-resistant closures, dispensing closures, and jars to a variety of end-markets with a focus on health & wellness segments, today announced that Jim Fitzgerald will join MRP as CEO and a member of the Board of Directors. MRP is majority-owned by an affiliate of Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake"), who invested in the Company in October 2021. Having served as President and CEO for 11 years, outgoing CEO Brian Bauerbach will retire from fulltime duties, but continue to partner with MRP and Clearlake as a member of the Board of Directors.
"We are thrilled to welcome Jim to the MRP executive team. Jim brings decades of experience in healthcare manufacturing platforms, most recently at medical device and components manufacturer Flexan, where he drove sustained organic revenue and earnings growth. His experience aligns well with MRP's value proposition of providing sustainable packaging solutions to our customers in our core end markets, including specialty food, household, and personal care, along with a deepening focus around health & wellness segments," said José E. Feliciano, Co-Founder and Managing Partner, and Arta Tabaee, Managing Director, of Clearlake. "On behalf of Clearlake and the Company, we would like to thank Brian for his leadership and commitment to MRP. Over the course of his 11 years leading the Company, he and his team have scaled the business into a supplier with products that are used every day by millions of consumers around the world. We know Brian shares our enthusiasm for MRP, and we look forward to continuing to benefit from his experience and expertise on the Board."
Mr. Fitzgerald has over 30 years of experience leading organizations in manufacturing focused on health and wellness markets. Prior to joining MRP, he served as President and CEO of Flexan, as well as Chief Operating Officer of The Institute for Transfusion Medicine and Executive Vice President for Vesta (now a Lubrizol subsidiary). Mr. Fitzgerald's knowledge of both manufacturing and health & wellness verticals, as well as a focus on driving growth and operational excellence at each of his prior roles, are well-aligned with MRP's strategy.
"I am excited to build upon the foundation that Brian and his team have established at MRP and to partner with Clearlake on the next leg of the Company's and my professional journeys. It is rare to have such a compelling opportunity at a business like MRP, and I am eager to join the Company and contribute to its next phase of growth," said Mr. Fitzgerald. "MRP's range of packaging solutions, combined with its core focus on sustainability, provides its customers offerings across health, wellness, and other verticals. I look forward to partnering with MRP's employees, valued customers, and the Clearlake team to capitalize on emerging growth trends in the packaging components industry."
"Jim reflects MRP's core values of focusing on customer satisfaction and operational excellence, and I believe he is the right successor to lead the Company's next phase of growth," added Mr. Bauerbach. "I'm honored to have been part of MRP's success over the past decade and know the Company is well positioned to accelerate its growth under Jim and Clearlake. I look forward to collaborating with Jim to ensure a smooth transition for all of our stakeholders and continuing to contribute to MRP's success as a member of the Board of Directors."
"This leadership transition, supported by our O.P.S.® framework and resources, will enable the Company to achieve its growth initiatives, both organically and by completing strategic acquisitions in this fragmented sector," added Dilshat Erkin, Vice President at Clearlake.
About Mold-Rite Packaging (MRP)
MRP provides rigid plastic packaging components used by millions of consumers while serving a diverse set of end-markets, with a primary focus on the health and wellness verticals. The Company has a library of 900+ tools used to support a product offering of 10,000+ SKUs and the ability to create a meaningfully higher count of variations. With a product line comprising child-resistant closures, dispensing closures, continuous thread caps, and jars, MRP specializes in flexible and efficient operations for small- to medium-sized customers with short-run production needs. MRP serves its customers through three production facilities in North America, and is headquartered in Plattsburgh, NY. More information is available at
About Clearlake
Founded in 2006, Clearlake Capital Group, L.P. is an investment firm, operating integrated businesses across private equity, credit, and other related strategies. With a sector-focused approach, the firm seeks to partner with world class management teams by providing patient, long term capital to dynamic businesses that can benefit from Clearlake's operational improvement framework, O.P.S.® The firm's core target sectors are industrials, consumer, and technology. Clearlake currently has over $60 billion of assets under management, and its senior investment principals have led or co-led over 300 investments. The firm is headquartered in Santa Monica, CA, with affiliate offices in Dallas, TX and London, UK. More information is available at and on Twitter @ClearlakeCap.
Media Contact:
Jennifer Hurson
Lambert & Co.
Ph: +1 845-507-0571
[email protected]
View original content to download multimedia:
SOURCE Mold-Rite Packaging; Clearlake Capital Group
Yahoo Finance's Jared Blikre breaks down Snap Inc.'s fourth quarter earnings.
Amazon (AMZN) reported fourth quarter results on Thursday and announced a fee hike for its Prime membership. The stock is soaring in after-hours.
Yahoo Finance's Pras Subramanian breaks down Ford's quarterly earnings and why the stock is falling.
It's been a little over a week since I warned investors — ahead of PayPal's (NASDAQ: PYPL) fourth-quarter earnings report, I might add — that this stock was far from cheap. Now that earnings are out, PayPal stock has plunged 25%, and some folks on Wall Street are questioning precisely how much PayPal is worth. Barclays Bank has cut its price target on PayPal to $200.
Investors have been very sensitive to any weakness shown by large tech players, especially Meta Platforms.
One analyst sees massive growth prospects for the electric vehicle company, and expects its shares to more than triple from recent levels.
Yahoo Finance's Jared Blikre reports Amazon's positive quarterly earnings and price increases.
It’s also how much investors have lost, so far, in the rising and falling fortunes of star manager Cathie Wood’s flagship ETF ARK Innovation (ARKK)  That’s based on calculations by Morningstar Inc., the fund analyst company. ARK Innovation declined to comment. “Investors have put in about $15.7 billion, and the current assets total is $11.6 billion,” calculates Morningstar portfolio strategist Amy Arnott.
How do you make sense of the current market conditions? We came off a strong bull year for stocks with the worst January in a long time – but the month ended, and February started with the best two-day action since April 2000. And in a quirk, that investors should note, small-cap stocks are showing strong signs of being heavily oversold. Small-caps took a harder hit in January’s swoon than the market giants, and according to JPMorgan's Chief Global Markets Strategist Marko Kolanovic, investors s
Amazon (NASDAQ: AMZN) reported fourth-quarter 2021 results after the market close on Thursday, Feb. 3 that pleased investors. The market's reaction is largely attributable to fourth-quarter operating income coming in higher than the company's guidance, along with earnings that crushed the Wall Street consensus estimate. Amazon's net quarterly sales grew 9% year over year to $137.4 billion, which was in line with the $137.4 billion Wall Street had expected.
Not for the first time in its rather eventful life as a publicly traded company, Nikola (NASDAQ: NKLA) took a solid hit to its share price on Wednesday. After a monster rival indicated it would spend more than previously disclosed on its electric vehicle (EV) efforts, Nikola's stock fell by almost 6% on the day. General Motors also said that it aims to spend more than the originally planned $35 billion through 2025 to get its EVs off the factory floor and onto the road.
Arete Research Partner and Co-Founder Brett Simpson joins Yahoo Finance Live to discuss Qualcomm's blowout earnings.
Bitcoin bull Michael Saylor weighs in on Facebook after the tech giant's earnings whiff sent the stock crashing.
MarketWatch Picks has highlighted these products and services because we think readers will find them useful; the MarketWatch News staff is not involved in creating this content. Finding good, trustworthy financial advice is tough. Then there are those investors who get a color, glossy postcard in the mail offering a free steak dinner and the chance to meet a savvy financial planner at an “investment seminar.”
The past month has seen some hefty swings in the markets. The main indexes are down since 2022 began, although they ended January and started February with a couple of strongly positive trading sessions. High volatility makes it difficult for investors to predict what’s likely to happen, and investors always crave predictability. Without it, the stock market is just a guessing game. But when markets are stable and predictable, investors can make more rational choices. So what’s needed here is a
In a sea of red linked to major earnings concerns, "not so bad" becomes the basis for bullishness.
Rising inflation and the threat of higher interest rates have crushed many of the market's favorite growth stocks over the past few months. That low price-to-sales ratio could quickly lure back growth-oriented investors in the near future.
Hundreds of Chinese companies are listed on U.S. markets. But which are the best Chinese stocks to buy or watch right now? , NetEase, Li Auto, Xpeng and BYD Co.. China is the world's most-populous nation and the second-largest economy with a booming urban middle class and amazing entrepreneurial activity.
Growth stocks can be great long-term investments to hang on to. A couple of stocks that are on a challenging path right now that I would stay away from are Ocugen (NASDAQ: OCGN) and ContextLogic (NASDAQ: WISH). Ocugen is a risky stock for many reasons.
It's Thursday, the Nasdaq Composite Index is plummeting — now down 2.7% — and it's taking the stock of Nvidia (NASDAQ: NVDA) along for the slide. Shares of the semiconductor giant were down 3.6% as of 1:10 p.m. ET today. In a note out earlier this week, analysts at reported that the semiconductor sector is in a slump despite a tight supply of microchips globally, with manufacturers having just five days' supply of chips on hand (versus closer to 40 days' worth as recently as 2019).


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort